The antitumor efficacy of a novel adenovirus-mediated anti-p21Ras single chain fragment variable antibody on human cancers in vitro and in vivo

International Journal of Oncology
Ju-Lun YangYing Luo

Abstract

Activated ras genes are found in a large number of human tumors, and therefore are one of important targets for cancer therapy. This study investigated the antitumor effects of a novel single chain fragment variable antibody (scFv) against ras protein, p21Ras. The anti-p21Ras scFv gene was constructed by phage display library from hybridoma KGHR1, and then subcloned into replication-defective adenovirus vector to obtain recombinant adenovirus KGHV100. Human tumor cell lines with high expression of p21Ras SW480, MDA-MB‑231, OVCAR-3, BEL-7402, as well as tumor cell line with low expression of p21Ras, SKOV3, were employed to investigate antitumor effects in vitro and in vivo. Fluorescence microscopy demonstrated that KGHV100 was able to express intracellularly anti-p21Ras scFv antibody in cultured tumor cells and in transplantation tumor cells. MTT, Transwell, colony formation, and flow cytometry analysis showed that KGHV100 led to significant growth arrest in tumor cells with high p21Ras expression, and induced G0/G1 cell cycle arrest in the studied tumor cell lines. In vivo, KGHV100 significantly inhibited tumor growth following intratumoral injection, and the survival rates of the mice were higher than the control group. These ...Continue Reading

References

Jan 4, 1989·Journal of the National Cancer Institute·M A GerosaG Della Valle
Aug 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·P H HandJ Schlom
May 24, 1994·Proceedings of the National Academy of Sciences of the United States of America·L DuanR J Pomerantz
Dec 15, 1993·Biochemical and Biophysical Research Communications·S BioccaA Cattaneo
Aug 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·W A MarascoS Y Chen
Jan 19, 1996·The Journal of Biological Chemistry·A J PelletierV Quaranta
Dec 1, 1995·The Journal of Clinical Investigation·J DeshaneD T Curiel
Apr 1, 1996·Journal of Occupational and Environmental Medicine·R NovaraP Vineis
Jan 1, 1997·Annual Review of Microbiology·I J Rondon, W A Marasco
Oct 16, 1999·Proceedings of the National Academy of Sciences of the United States of America·M VisintinA Cattaneo
Feb 15, 2000·European Journal of Biochemistry·M LenerS Biocca
Jul 19, 2001·Journal of the National Cancer Institute·A A Adjei
Jul 4, 2002·Journal of the National Cancer Institute·Silvana CanevariMariangela Figini
Jan 2, 2003·Nature Reviews. Cancer·Julian Downward
Sep 15, 2009·Human Gene Therapy·Sufi Mary Thomas, Jennifer Rubin Grandis
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Jul 23, 2011·Genes & Cancer·Alberto Fernández-Medarde, Eugenio Santos
Jul 23, 2011·Genes & Cancer·Stephan GysinFrank McCormick
Jan 14, 2012·Oral Oncology·Avaniyapuram Kannan MuruganNobuo Tsuchida
Jul 31, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Mohammad SakiH Peter Rodemann

❮ Previous
Next ❯

Citations

Mar 6, 2017·International Journal of Molecular Medicine·Shuang BaiJu-Lun Yang
Aug 6, 2017·Cold Spring Harbor Perspectives in Medicine·Dehua PeiHui Liao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
J W RoccoB W O'Malley
© 2022 Meta ULC. All rights reserved